BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31272582)

  • 1. Identification of a Novel ZBTB20-JAK2 Fusion by Mate-Pair Sequencing in a Young Adult With B-Lymphoblastic Leukemia/Lymphoma.
    Peterson JF; Blackburn PR; Webley MR; Pearce KE; Williamson CM; Vasmatzis G; Smadbeck JB; Bieliauskas SL; Reichard KK; Ketterling RP; Baughn LB; Greipp PT
    Mayo Clin Proc; 2019 Jul; 94(7):1381-1384. PubMed ID: 31272582
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnostic challenges and clinical course of a myeloid/lymphoid neoplasm with eosinophilia and
    Lee WY; Pfau RB; Choi SM; Yang J; Xiao H; Putnam EM; Ryan RJ; Bixby DL; Shao L
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia.
    Mayfield JR; Czuchlewski DR; Gale JM; Matlawska-Wasowska K; Vasef MA; Nickl C; Pickett G; Ness SA; Winter SS
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27860260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility.
    Lin M; Nebral K; Gertzen CGW; Ganmore I; Haas OA; Bhatia S; Fischer U; Kuhlen M; Gohlke H; Izraeli S; Trka J; Hu J; Borkhardt A; Hauer J; Auer F
    Leukemia; 2019 Sep; 33(9):2331-2335. PubMed ID: 30967616
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).
    Kawamura M; Taki T; Kaku H; Ohki K; Hayashi Y
    Genes Chromosomes Cancer; 2015 Jul; 54(7):401-8. PubMed ID: 25951811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRLF2 and JAK2 in B-progenitor acute lymphoblastic leukemia: a novel association in oncogenesis.
    Roll JD; Reuther GW
    Cancer Res; 2010 Oct; 70(19):7347-52. PubMed ID: 20807819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of RNPC3 as a novel JAK2 fusion partner gene in B-acute lymphoblastic leukemia refractory to combination therapy including ruxolitinib.
    Chen X; Wang F; Zhang Y; Ma X; Liu M; Cao P; Zhou L; Wang L; Zhang X; Wang T; Liu H
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1110. PubMed ID: 31885183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia.
    Poitras JL; Dal Cin P; Aster JC; Deangelo DJ; Morton CC
    Genes Chromosomes Cancer; 2008 Oct; 47(10):884-9. PubMed ID: 18618714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia.
    Downes CEJ; Rehn J; Heatley SL; Yeung D; McClure BJ; White DL
    Br J Haematol; 2022 Feb; 196(3):700-705. PubMed ID: 34697799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion.
    Yano M; Imamura T; Asai D; Kiyokawa N; Nakabayashi K; Matsumoto K; Deguchi T; Hashii Y; Honda YK; Hasegawa D; Sasahara Y; Ishii M; Kosaka Y; Kato K; Shima M; Hori H; Yumura-Yagi K; Hara J; Oda M; Horibe K; Ichikawa H; Sato A
    Br J Haematol; 2015 Dec; 171(5):813-7. PubMed ID: 26404892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia.
    Chapiro E; Russell L; Lainey E; Kaltenbach S; Ragu C; Della-Valle V; Hanssens K; Macintyre EA; Radford-Weiss I; Delabesse E; Cavé H; Mercher T; Harrison CJ; Nguyen-Khac F; Dubreuil P; Bernard OA
    Leukemia; 2010 Mar; 24(3):642-5. PubMed ID: 19907440
    [No Abstract]   [Full Text] [Related]  

  • 12. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience.
    Konoplev S; Lu X; Konopleva M; Jain N; Ouyang J; Goswami M; Roberts KG; Valentine M; Mullighan CG; Bueso-Ramos C; Zweidler-McKay PA; Jorgensen JL; Wang SA
    Am J Clin Pathol; 2017 Apr; 147(4):357-363. PubMed ID: 28340183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of E627 and R683 interaction is responsible for B-cell acute lymphoblastic leukemia caused by JAK2 R683G(S) mutations.
    Wu QY; Guo HY; Li F; Li ZY; Zeng LY; Xu KL
    Leuk Lymphoma; 2013 Dec; 54(12):2693-700. PubMed ID: 23452118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of R683S (G) genetic mutations on the JAK2 activity, structure and stability.
    Li F; Guo HY; Wang M; Geng HL; Bian MR; Cao J; Chen C; Zeng LY; Wang XY; Wu QY
    Int J Biol Macromol; 2013 Sep; 60():186-95. PubMed ID: 23748007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ph-like B-cell acute lymphoblastic leukemia with ZEB2-JAK2 fusion gene positivity: a case report].
    Shen K; Wang M; Hu DY; Guo YS; Chen SN
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):606. PubMed ID: 37749046
    [No Abstract]   [Full Text] [Related]  

  • 16. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
    Herold T; Schneider S; Metzeler KH; Neumann M; Hartmann L; Roberts KG; Konstandin NP; Greif PA; Bräundl K; Ksienzyk B; Huk N; Schneider I; Zellmeier E; Jurinovic V; Mansmann U; Hiddemann W; Mullighan CG; Bohlander SK; Spiekermann K; Hoelzer D; Brüggemann M; Baldus CD; Dreyling M; Gökbuget N
    Haematologica; 2017 Jan; 102(1):130-138. PubMed ID: 27561722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.
    Imamura T; Kiyokawa N; Kato M; Imai C; Okamoto Y; Yano M; Ohki K; Yamashita Y; Kodama Y; Saito A; Mori M; Ishimaru S; Deguchi T; Hashii Y; Shimomura Y; Hori T; Kato K; Goto H; Ogawa C; Koh K; Taki T; Manabe A; Sato A; Kikuta A; Adachi S; Horibe K; Ohara A; Watanabe A; Kawano Y; Ishii E; Shimada H
    Blood Cancer J; 2016 May; 6(5):e419. PubMed ID: 27176795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
    Tomoyasu C; Imamura T; Tomii T; Yano M; Asai D; Goto H; Shimada A; Sanada M; Iwamoto S; Takita J; Minegishi M; Inukai T; Sugita K; Hosoi H
    Int J Hematol; 2018 Sep; 108(3):312-318. PubMed ID: 29786757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.
    Heilmann AM; Schrock AB; He J; Nahas M; Curran K; Shukla N; Cramer S; Draper L; Verma A; Erlich R; Ross J; Stephens P; Miller VA; Ali SM; Verglio JA; Tallman MS; Mughal TI
    Leukemia; 2017 Sep; 31(9):1989-1992. PubMed ID: 28552906
    [No Abstract]   [Full Text] [Related]  

  • 20. The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome.
    Miyamoto N; Sugita K; Goi K; Inukai T; Lijima K; Tezuka T; Kojika S; Nakamura M; Kagami K; Nakazawa S
    Leukemia; 2001 Nov; 15(11):1758-68. PubMed ID: 11681418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.